Biological insights from 108 schizophrenia-associated genetic loci

Saha, S., Chant, D. & McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry 64, 1123–1131 (2007)

World Health Organization. The Global Burden of Disease: 2004 Update (WHO Press, 2008)

Knapp, M., Mangalore, R. & Simon, J. The global costs of schizophrenia. Schizophr. Bull. 30, 279–293 (2004)

Lieberman, J. A. et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353, 1209–1223 (2005)

Carlsson, A. & Lindqvist, M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140–144 (1963)

van Rossum, J. M. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch. Int. Pharmacodyn. Ther. 160, 492–494 (1966)

Lichtenstein, P. et al. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol. Med. 36, 1417–1425 (2006)

Sullivan, P. F., Kendler, K. S. & Neale, M. C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187–1192 (2003)

Sullivan, P. F., Daly, M. J. & O’Donovan, M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nature Rev. Genet. 13, 537–551 (2012)

International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009)

Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genet. 45, 1150–1159 (2013)

Ikeda, M. et al. Genome-wide association study of schizophrenia in a Japanese population. Biol. Psychiatry 69, 472–478 (2011)

Hamshere, M. L. et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 18, 708–712 (2013)

O’Donovan, M. C. et al. Identification of novel schizophrenia loci by genome-wide association and follow-up. Nature Genet. 40, 1053–1055 (2008)

Rietschel, M. et al. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol. Psychiatry 17, 906–917 (2012)

Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifies five new schizophrenia loci. Nature Genet. 43, 969–976 (2011)

Irish Schizophrenia Genomics Consortium & Wellcome Trust Case Control Consortium. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol. Psychiatry 72, 620–628 (2012)

Shi, J. et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753–757 (2009)

Shi, Y. et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nature Genet. 43, 1224–1227 (2011)

Stefansson, H. et al. Common variants conferring risk of schizophrenia. Nature 460, 744–747 (2009)

Steinberg, S. et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum. Mol. Genet. 20, 4076–4081 (2011)

Yue, W. H. et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nature Genet. 43, 1228–1231 (2011)

Lencz, T. et al. Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nature Commun. 4, 2739 (2013)

Psychiatric GWAS Consortium. A framework for interpreting genomewide association studies of psychiatric disorders. Mol. Psychiatry 14, 10–17 (2009)

The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010)

Begum, F., Ghosh, D., Tseng, G. C. & Feingold, E. Comprehensive literature review and statistical considerations for GWAS meta-analysis. Nucleic Acids Res. 40, 3777–3784 (2012)

Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832–838 (2010)

Jostins, L. et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012)

Yang, J. et al. Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet. 19, 807–812 (2011)

Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Preprint at http://dx.doi.org/10.1101/002931 (2014)

Ferreira, M. A. et al. Collaborative genome-wide association supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genet. 40, 1056–1058 (2008)

Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013)

Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 506, 185–190 (2014)

Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 506, 179–184 (2014)

Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142–153 (2012)

Wellcome Trust Case Control Consortium Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature Genet. 44, 1294–1301 (2012)

Nicolae, D. L. et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888 (2010)

Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012)

Richards, A. L. et al. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Mol. Psychiatry 17, 193–201 (2012)

Wright, F. A. et al. Heritability and genomics of gene expression in peripheral blood. Nature Genet. 46, 430–437 (2014)

Doyle, J. P. et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749–762 (2008)

Tkachev, D. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798–805 (2003)

Benros, M. E., Mortensen, P. B. & Eaton, W. W. Autoimmune diseases and infections as risk factors for schizophrenia. Ann. NY Acad. Sci. 1262, 56–66 (2012)

Holmans, P. et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85, 13–24 (2009)

Lee, P. H., O’Dushlaine, C., Thomas, B. & Purcell, S. InRich: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28, 1797–1799 (2012)

Lee, S. H., Goddard, M. E., Wray, N. R. & Visscher, P. M. A better coefficient of determination for genetic profile analysis. Genet. Epidemiol. 36, 214–224 (2012)

Gottesman, I. I. & Gould, T. D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636–645 (2003)

Insel, T. et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167, 748–751 (2010)

Lips, E. S. et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol. Psychiatry 17, 996–1006 (2012)

Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005)